April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Role of Inflammatory Leukocytes in Ischemic Retinopathy
Author Affiliations & Notes
  • Francois Binet
    Research center, Maisonneuve Rosemont Hospital, Montreal, Quebec, Canada
  • Agustin Cerani
    Research center, Maisonneuve Rosemont Hospital, Montreal, Quebec, Canada
  • Nicholas Sitaras
    Research center, Maisonneuve Rosemont Hospital, Montreal, Quebec, Canada
  • Sophie Tremblay
    Research center, Maisonneuve Rosemont Hospital, Montreal, Quebec, Canada
  • Flavio Rezende
    Research center, Maisonneuve Rosemont Hospital, Montreal, Quebec, Canada
  • Eric Lapalme
    Research center, Maisonneuve Rosemont Hospital, Montreal, Quebec, Canada
  • Sandra Favret
    Research center, Maisonneuve Rosemont Hospital, Montreal, Quebec, Canada
  • Przemyslaw Sapieha
    Research center, Maisonneuve Rosemont Hospital, Montreal, Quebec, Canada
  • Footnotes
    Commercial Relationships  Francois Binet, None; Agustin Cerani, None; Nicholas Sitaras, None; Sophie Tremblay, None; Flavio Rezende, None; Eric Lapalme, None; Sandra Favret, None; Przemyslaw Sapieha, None
  • Footnotes
    Support  CIHR, CNIB
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3978. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Francois Binet, Agustin Cerani, Nicholas Sitaras, Sophie Tremblay, Flavio Rezende, Eric Lapalme, Sandra Favret, Przemyslaw Sapieha; Role of Inflammatory Leukocytes in Ischemic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3978.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Ischemic retinopathies (such as retinopathy of prematurity and diabetic retinopathy) are major causes of blindness across all age groups. Several reports have described an inflammatory contribution to the pathogenesis of the disease. For instance, chemokines such as MCP-1 or MIP-1a have been demonstrated to be implicated in the progression of pathological neovascularization. Although neutrophils are the most abundant leukocytes in the human blood, their contribution to retinopathy remains elusive. Here we investigated the role of neutrophils in a mouse model of oxygen-induced retinopathy (OIR), with particular emphasis on the proliferative phase of the disease. We also looked at the implication of netrin-1, an axonal guidance cue recently demonstrated to be implicated in the control of inflammation and has interestingly been proven to inhibit chemotaxis of the neutrophil.

Methods: : Mice were subjected to 75% O2 from postnatal day 7 (P7) to P12. Depletion of neutrophils was accomplished by systemic injections at P10 and P12 of the Gr-1 neutrophil-neutralizing antibody. Mouse retinas were analyzed for extent of vascular regeneration at P17. The efficacy of neutrophil depletion was determined on bloodsmears at P14. The presence of neutrophils was determined using a myeloperoxydase (MPO) enzymatic assay. Netrin-1 was injected intravitreally at P14 and retinas were analyzed at P17 for revascularization using flatmounts and expression of angiogenic and inflammatory genes using real-time PCR.

Results: : We observed an increase in MPO activity in OIR retinas at P14 and a peak at P17 indicative of a neutrophil infiltration. Depletion of neutrophils with the Gr-1 antibody to less than 10% of total leukocytes (non-treated : 25%) effectively enhanced vascular regeneration by ~5%. Netrin-1 addition was also demonstrated to be a promoter of retinal revascularization by enhancement of expression of angiogenic markers (i.e.VEGF) and downregulation of pro-inflammatory genes.

Conclusions: : These results demonstrate that neutrophils partake actively in delaying physiological revascularization in OIR. Future studies will determine the merit of interfering with this population of leukocytes as a therapeutic strategy for ischemic retinopathies.

Keywords: retinopathy of prematurity • inflammation • hypoxia 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×